![GEF-H1 Antibody[35429]产品图](https://img1.dxycdn.com/p/s14/2025/0922/359/6146153295428599691.jpg)
- 询价
- Signalway Antibody
- 35429
- 2025年09月22日
- WB
- Rabbit
- Human
企业认证
相关产品推荐更多 >
![MMP14 Polyclonal Antibody Cy3 Conjugated[C90176Cy3]](https://img1.dxycdn.com/p/s14/2025/0922/498/0460884283108299691.jpg!wh200)
![ZNF404 Antibody[39622]](https://img1.dxycdn.com/p/s14/2025/0922/359/6146153295428599691.jpg!wh200)
![DNAJA1 Conjugated Antibody[C36538]](https://img1.dxycdn.com/p/s14/2025/0923/278/4431488150116040791.jpg!wh200)
![RFX3 Polyclonal Antibody[48794]](https://img1.dxycdn.com/p/s14/2025/0922/632/2321321568067599691.jpg!wh200)
![L-plastin (Phospho-Ser5) Antibody[12455]](https://img1.dxycdn.com/p/s14/2025/0922/568/0046652811090600791.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶现货试剂/标准品，库存足，周末发货Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant protein fragment contain a sequence corresponding to a region within amino acids 115 and 302 of GEF-H1.
- 形态：
liquid
- 保存条件：
Store at -20˚C
- 克隆性：
Polyclonal
- 适应物种：
Human
- 保质期：
12 months
- 抗原来源：
Rabbit
- 供应商：
南京赛戈巍生物科技有限公司
- 宿主：
Rabbit
- 应用范围：
WB
- 靶点：
Uniprot：Q92974
- 抗体英文名：
GEF-H1 Antibody
- 规格：
50ul/100ul
配方:Rabbit IgG in 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
应用详情:Western blotting: 1:500-1:3000
图片:
Sample (30 ug of whole cell lysate)
A: K562
5% SDS PAGE
#35429 diluted at 1:1000
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验佚名 人工合成的H 1 受体阻断药多具有乙基胺的共同结构， Ar 1 和Ar 2 可为苯环或杂环，X可为氮、氧或碳，并与主核相联。乙基胺与组胺的侧链相似，对H 1 受体有较大亲和力，但无内在活性，故能竞争性阻断之。 【药理
Mini-Antibody Affinity Chromatography of Lysozyme
Multiple noncovalent forces do play a role in the binding between a protein antigen and an antibody directed against that protein. An antigen is bound by the antigen binding site of an antibody that consists of three hypervariable segments
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
技术资料暂无技术资料 索取技术资料
